As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
As the world's only subcutaneous implantable cardioverter defibrillator, the S-ICD System protects patients from sudden cardiac arrest (SCA), while leaving their heart untouched.
BioControl Medical, a privately held medical device company headquartered in Yehud, Israel with offices in New Hope, Minnesota, develops implantable medical devices to treat disorders of the autonomic nervous system. Our objective is to improve quality of